Published in

Springer (part of Springer Nature), Annals of Surgical Oncology, 2(14), p. 992-997

DOI: 10.1245/s10434-006-9217-3

Links

Tools

Export citation

Search in Google Scholar

Prognostic Factors for Pulmonary Metastasectomy in Hepatocellular Carcinoma

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Purpose: To identify the prognostic factors for pulmonary metastasectomy (PM-ectomy) in hepatocellular carcinoma (HCC) . Patients and methods: We conducted a retrospective review of patients with pulmonary metastases (PM ) from HCC who had undergone curative PM-ectomy at National Taiwan University Hospital between 1990 and 2004. Univariate (log-rank) and multivariate (Cox's model) analyses of survival were used to identify the significant prognostic factors. Results: In total, 34 patients were eligible for curative PM-ectomy. The overall survival rates (Kaplan-Meier) after PM-ectomy were 65.2% and 27.5% at 2 and 5 years, respectively. High alpha- fetoprotein level, positive hepatic resection margin, and short disease-free interval (DFI) were unfavorable factors for overall survival from univariate analysis, however, only DFI (P = 0.028) was identified as an independently prognostic factor by multivariate analysis. Bilateral distribution and more PMs were unfavorable factors for PM- free survival from univariate analysis, with only PM number identified as an independent prognostic factor by multivariate analysis (P = 0.017). Conclusion: Patients with longer DFIs and fewer PMs can benefit from PM-ectomy in HCC . ; 附設醫院創傷醫學部 ; 醫學院附設醫院 ; 期刊論文